• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在体外循环手术期间用凝血酶原片段1.2检测法监测凝血酶生成

Monitoring thrombin generation with prothrombin fragment 1.2 assay during cardiopulmonary bypass surgery.

作者信息

Knudsen L, Hasenkam J M, Kure H H, Hughes P, Bellaiche L, Ahlburg P, Djurhuus C

机构信息

Dept. of Clinical Immunology, Skejby Sygehus, Aarhus University Hospital, Denmark.

出版信息

Thromb Res. 1996 Oct 1;84(1):45-54. doi: 10.1016/0049-3848(96)00160-0.

DOI:10.1016/0049-3848(96)00160-0
PMID:8885146
Abstract

UNLABELLED

Despite high plasma levels of heparin during cardiopulmonary bypass surgery, activation of the coagulation system has been reported. We hypothesize that the coagulation system activity most appropriately could be assessed by molecular markers of thrombin generation. The aim of the present study was to describe the changes in thrombin generation during CPB, using prothrombin fragment F1 + 2 (F1.2) as an indicator and evaluate different blood sampling regimens for interpretation of the F1.2 measurements. Twenty patients, operated under extracorporeal circulation with coronary artery bypass grafting (CABG), comprised the study material. The heparin levels were maintained above 2.5 IU/ml throughout the bypass procedure and the functional AT-III level was kept above 0.5 U/ml. Despite of this anticipated inactivation of the coagulation system, the concentrations of F1.2 and FpA increased throughout CPB, particularly after release of the aortic crossclamp. F1.2 and FpA correlated significantly (R = 0.69). No statistically significant correlation was found between F1.2 formation rate and age, bodyweight, baseline ACT, ACT after 200 IU heparin/kg, average heparin concentration during CPB or average AT-III level during CPB.

CONCLUSIONS

Thrombin formation seems to be a continuous process during CPB despite adequate heparinization. The pattern of thrombin generation can be assessed most appropriately in terms of F1.2 generation rate. Extraordinary high levels of F1.2 were seen after release of the aortic crossclamp, indicating that the periods before and after aortic crossclamping should be evaluated separately.

摘要

未标记

尽管在心肺转流手术期间血浆肝素水平很高,但仍有报道称凝血系统被激活。我们假设凝血系统活性最适宜通过凝血酶生成的分子标志物来评估。本研究的目的是使用凝血酶原片段F1 + 2(F1.2)作为指标描述心肺转流期间凝血酶生成的变化,并评估不同的采血方案以解释F1.2测量结果。20例接受体外循环冠状动脉搭桥术(CABG)的患者构成了研究材料。在整个转流过程中,肝素水平维持在2.5 IU/ml以上,功能性抗凝血酶III(AT-III)水平保持在0.5 U/ml以上。尽管预期凝血系统会失活,但在整个心肺转流期间,F1.2和纤维蛋白肽A(FpA)的浓度均升高,尤其是在松开主动脉阻断钳后。F1.2和FpA显著相关(R = 0.69)。未发现F1.2生成率与年龄、体重、基线活化凝血时间(ACT)、200 IU肝素/kg后的ACT、心肺转流期间的平均肝素浓度或心肺转流期间的平均AT-III水平之间存在统计学显著相关性。

结论

尽管肝素化充分,但在心肺转流期间凝血酶形成似乎是一个持续的过程。凝血酶生成模式最适宜根据F1.2生成率进行评估。在松开主动脉阻断钳后观察到F1.2水平异常升高,表明主动脉阻断前后的时期应分别评估。

相似文献

1
Monitoring thrombin generation with prothrombin fragment 1.2 assay during cardiopulmonary bypass surgery.在体外循环手术期间用凝血酶原片段1.2检测法监测凝血酶生成
Thromb Res. 1996 Oct 1;84(1):45-54. doi: 10.1016/0049-3848(96)00160-0.
2
Thrombin production, inactivation and expression during open heart surgery measured by assays for activation fragments including a new ELISA for prothrombin fragment F1 + 2.通过针对活化片段的检测方法,包括一种用于凝血酶原片段F1 + 2的新型酶联免疫吸附测定法,来测量心脏直视手术期间的凝血酶生成、失活和表达。
Thromb Haemost. 1993 Aug 2;70(2):253-8.
3
Thrombin generation during cardiopulmonary bypass using heparin-coated or standard circuits.使用肝素涂层或标准回路进行体外循环期间的凝血酶生成。
Scand J Thorac Cardiovasc Surg. 1995;29(4):157-65. doi: 10.3109/14017439509107224.
4
Characterization of prothrombin activation during cardiac surgery by hemostatic molecular markers.通过止血分子标志物对心脏手术期间凝血酶原激活的特征分析。
Anesthesiology. 1994 Mar;80(3):520-6. doi: 10.1097/00000542-199403000-00007.
5
Thrombin generation during cardiac surgery: is heparin the ideal anticoagulant?心脏手术中的凝血酶生成:肝素是理想的抗凝剂吗?
Thromb Haemost. 1993 Aug 2;70(2):259-62.
6
Prothrombin fragment 1 + 2, thrombin-antithrombin III-complexes and fibrinopeptide A in spontaneously clotting whole blood in vitro. Effects of heparin addition and antithrombin III deficiency.体外自凝全血中的凝血酶原片段1+2、凝血酶-抗凝血酶III复合物及纤维蛋白肽A。添加肝素及抗凝血酶III缺乏的影响。
Thromb Haemost. 1994 Jan;71(1):49-53.
7
Surface-bound heparin fails to reduce thrombin formation during clinical cardiopulmonary bypass.在临床体外循环期间,表面结合的肝素未能减少凝血酶的形成。
J Thorac Cardiovasc Surg. 1996 Jan;111(1):1-11; discussion 11-2. doi: 10.1016/s0022-5223(96)70395-1.
8
Reducing thrombin formation during cardiopulmonary bypass: is there a benefit of the additional anticoagulant action of aprotinin?在体外循环期间减少凝血酶形成:抑肽酶的额外抗凝作用是否有益?
J Cardiovasc Pharmacol. 1996;27 Suppl 1:S50-7. doi: 10.1097/00005344-199600001-00011.
9
Another point of view on the mechanism of thrombin generation during cardiopulmonary bypass: role of tissue factor pathway inhibitor.关于体外循环期间凝血酶生成机制的另一种观点:组织因子途径抑制物的作用。
J Cardiothorac Vasc Anesth. 2001 Feb;15(1):60-4. doi: 10.1053/jcan.2001.20278.
10
Anticoagulation of children undergoing cardiopulmonary bypass is overestimated by current monitoring techniques.目前的监测技术高估了接受体外循环的儿童的抗凝情况。
Arch Surg. 2000 Sep;135(9):1042-7. doi: 10.1001/archsurg.135.9.1042.

引用本文的文献

1
Strategies to attenuate maladaptive inflammatory response associated with cardiopulmonary bypass.减轻与体外循环相关的适应性炎症反应的策略。
Front Surg. 2024 Jul 3;11:1224068. doi: 10.3389/fsurg.2024.1224068. eCollection 2024.
2
The Developing Balance of Thrombosis and Hemorrhage in Pediatric Surgery: Clinical Implications of Age-Related Changes in Hemostasis.小儿外科学中血栓形成与出血的平衡变化:止血中年龄相关变化的临床意义。
Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029620929092. doi: 10.1177/1076029620929092.
3
Combination of aptamer and drug for reversible anticoagulation in cardiopulmonary bypass.
适配体与药物联合用于心肺转流术的可逆抗凝。
Nat Biotechnol. 2018 Aug;36(7):606-613. doi: 10.1038/nbt.4153. Epub 2018 Jun 4.
4
Impact of a phosphorylcholine-coated cardiac bypass circuit on blood loss and platelet function: a prospective, randomized study.磷酸胆碱涂层心脏搭桥回路对失血和血小板功能的影响:一项前瞻性随机研究。
J Extra Corpor Technol. 2012 Mar;44(1):5-9.
5
Coagulation and fibrinolytic protein kinetics in cardiopulmonary bypass.体外循环中的凝血和纤溶蛋白动力学
J Thromb Thrombolysis. 2009 Jan;27(1):95-104. doi: 10.1007/s11239-007-0187-5. Epub 2008 Jan 23.
6
Children undergoing cardiac surgery for complex cardiac defects show imbalance between pro- and anti-thrombotic activity.因复杂心脏缺陷接受心脏手术的儿童表现出促血栓形成和抗血栓形成活性之间的失衡。
Crit Care. 2006;10(6):R165. doi: 10.1186/cc5108.
7
Coagulation disorders of cardiopulmonary bypass: a review.体外循环凝血障碍:综述
Intensive Care Med. 2004 Oct;30(10):1873-81. doi: 10.1007/s00134-004-2388-0. Epub 2004 Jul 24.